CDH1 and neoplasm: In the in vivo experimental part, in mice treated with emodin at a dose of 40 mg/kg (p.o), tumor growth inhibition was associated with decreased VEGF + cells, decreased expression of TCF4, cyclin D1, c-Myc, and N-cadherin, and increased expression of E-cadherin [12].